2008
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and Relapsing Babesiosis in Immunocompromised Patients. Clinical Infectious Diseases 2008, 46: 370-376. PMID: 18181735, DOI: 10.1086/525852.Peer-Reviewed Original ResearchConceptsCase patientsAntibabesial treatmentClinical courseControl subjectsBlood smearsRetrospective case-control studyOptimal treatment regimenStandard antimicrobial therapyMalaria-like illnessBabesia microti infectionMost cases patientsCase-control studyCourse of therapyB-cell lymphomaAdministration of atovaquoneImmunologic statusStandard therapyAntimicrobial regimenSuch patientsTreatment regimenMicroti infectionAntimicrobial therapyPersistent infectionCell lymphomaAcute babesiosis
1993
Cutaneous Cryptococcosis in a Patient with Cutaneous T Cell Lymphoma Receiving Therapy with Photopheresis and Methotrexate
Frieden T, Bia F, Heald P, Eisen R, Patterson T, Edelson R. Cutaneous Cryptococcosis in a Patient with Cutaneous T Cell Lymphoma Receiving Therapy with Photopheresis and Methotrexate. Clinical Infectious Diseases 1993, 17: 776-778. PMID: 8268362, DOI: 10.1093/clinids/17.4.776.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmphotericin BChemotherapy, AdjuvantCryptococcosisDermatomycosesHumansImmunocompromised HostLymphoma, T-Cell, CutaneousMaleMethotrexatePhotopheresis